drug · antibody
patient view →etigilimab
Phase 2updated 2mo agoby $MREO Mereo BioPharma Group plc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 1 2, with 1 investigational indication.
targets
T-cell immunoreceptor with Ig and ITIM domains
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that